Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease
- 1 August 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 356 (9230) , 610-612
- https://doi.org/10.1016/s0140-6736(00)02598-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Review article: potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2000
- Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaGastroenterology, 2000
- The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomachEuropean Journal of Gastroenterology & Hepatology, 2000
- Lack of effect of acid suppression therapy on gastric atrophyGastroenterology, 1999
- On demand therapy with omeprazole for the long‐term management of patients with heartburn without oesophagitis—a placebo‐controlled randomized trialAlimentary Pharmacology & Therapeutics, 1999
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Omeprazole (OME) or antireflux surgery (ARS) in the long term management of gastroesophageal reflux disease (GERD): Results of a multicentre, randomised clinical trialGastroenterology, 1998
- Gastric Acid, Acid-Suppressing Drugs, and Bacterial GastroenteritisEpidemiology, 1997
- Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or FundoplicationNew England Journal of Medicine, 1996
- Enterochromaffin-Like Cell Carcinoids of Gastric Mucosa in Rats after Life-Long Inhibition of Gastric SecretionDigestion, 1986